Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia

被引：7
作者：
Wei, Hui [1 ,2 ,3 ,4 ]
Zhou, Chunlin [3 ,4 ]
Lin, Dong [3 ,4 ]
Liu, Bingcheng [3 ,4 ]
Li, Yan [3 ,4 ]
Zhao, Xingli [3 ,4 ]
Wei, Shuning [3 ,4 ]
Gong, Benfa [3 ,4 ]
Liu, Kaiqi [3 ,4 ]
Gong, Xiaoyuan [3 ,4 ]
Liu, Yuntao [3 ,4 ]
Zhang, Guangji [3 ,4 ]
Chen, Jiayuan [1 ]
Zhang, Junping [3 ,4 ]
Jin, Jingjing [3 ,4 ]
Qiu, Shaowei [3 ,4 ]
Gu, Runxia [3 ,4 ]
Wang, Ying [2 ,3 ,4 ]
Mi, Yingchan [1 ,2 ,3 ,4 ]
Wang, Jianxiang [1 ,2 ,3 ,4 ]
机构：
[1] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China
[2] Chinese Acad Med Sci, Inst Hematol, Natl Clin Res Ctr Blood Dis, Tianjin, Peoples R China
[3] Chinese Acad Med Sci, Inst Hematol, Leukemia Ctr, Tianjin, Peoples R China
[4] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China
来源：
HAEMATOLOGICA | 2021年 / 106卷 / 05期
基金：
中国国家自然科学基金;
关键词：
RANDOMIZED-TRIAL; ADULTS; DAUNORUBICIN; AML;
D O I：
10.3324/haematol.2020.267526
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1491 / 1495
页数：5
相关论文
共 14 条
  • [1] A randomized study of high-dose cytarabine in induction in acute myeloid leukemia
    Bishop, JF
    Matthews, JP
    Young, GA
    Szer, J
    Gillett, A
    Joshua, D
    Bradstock, K
    Enno, A
    Wolf, MM
    Fox, R
    Cobcroft, R
    Herrmann, R
    VanDerWeyden, M
    Lowenthal, RM
    Page, F
    Garson, OM
    Juneja, S
    [J]. BLOOD, 1996, 87 (05) : 1710 - 1717
  • [2] Treatment of Core-Binding-Factor in Acute Myelogenous Leukemia With Fludarabine, Cytarabine, and Granulocyte Colony-stimulating Factor Results in Improved Event-free Survival
    Borthakur, Gautam
    Kantarjian, Hagop
    Wang, Xuemei
    Plunkett, William K., Jr.
    Gandhi, Varsha V.
    Faderl, Stefan
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Pierce, Sherry
    Estey, Elihu H.
    [J]. CANCER, 2008, 113 (11) : 3181 - 3185
  • [3] Burnett AK, 2013, BLOOD, V122, P358
  • [4] Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
    Doehner, Hartmut
    Estey, Elihu
    Grimwade, David
    Amadori, Sergio
    Appelbaum, Frederick R.
    Buechner, Thomas
    Dombret, Herve
    Ebert, Benjamin L.
    Fenaux, Pierre
    Larson, Richard A.
    Levine, Ross L.
    Lo-Coco, Francesco
    Naoe, Tomoki
    Niederwieser, Dietger
    Ossenkoppele, Gert J.
    Sanz, Miguel
    Sierra, Jorge
    Tallman, Martin S.
    Tien, Hwei-Fang
    Wei, Andrew H.
    Lowenberg, Bob
    Bloomfield, Clara D.
    [J]. BLOOD, 2017, 129 (04) : 424 - 447
  • [5] Anthracycline Dose Intensification in Acute Myeloid Leukemia
    Fernandez, Hugo F.
    Sun, Zhuoxin
    Yao, Xiaopan
    Litzow, Mark R.
    Luger, Selina M.
    Paietta, Elisabeth M.
    Racevskis, Janis
    Dewald, Gordon W.
    Ketterling, Rhett P.
    Bennett, John M.
    Rowe, Jacob M.
    Lazarus, Hillard M.
    Tallman, Martin S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) : 1249 - 1259
  • [6] Prognostic Significance of CEBPA Mutations in a Large Cohort of Younger Adult Patients With Acute Myeloid Leukemia: Impact of Double CEBPA Mutations and the Interaction With FLT3 and NPM1 Mutations
    Green, Claire L.
    Koo, Kenneth K.
    Hills, Robert K.
    Burnett, Alan K.
    Linch, David C.
    Gale, Rosemary E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2739 - 2747
  • [7] A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia
    Lee, Je-Hwan
    Joo, Young-Don
    Kim, Hawk
    Bae, Sung Hwa
    Kim, Min Kyoung
    Zang, Dae Young
    Lee, Jung-Lim
    Lee, Gyeong Won
    Lee, Jung-Hee
    Park, Jae-Hoo
    Kim, Dae-Young
    Lee, Won-Sik
    Ryoo, Hun Mo
    Hyun, Myung Soo
    Kim, Hyo Jung
    Min, Young Joo
    Jang, Yae-Eun
    Lee, Kyoo-Hyung
    [J]. BLOOD, 2011, 118 (14) : 3832 - 3841
  • [8] Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups
    Luskin, Marlise R.
    Lee, Ju-Whei
    Fernandez, Hugo F.
    Abdel-Wahab, Omar
    Bennett, John M.
    Ketterling, Rhett P.
    Lazarus, Hillard M.
    Levine, Ross L.
    Litzow, Mark R.
    Paietta, Elisabeth M.
    Patel, Jay P.
    Racevskis, Janis
    Rowe, Jacob M.
    Tallman, Martin S.
    Sun, Zhuoxin
    Luger, Selina M.
    [J]. BLOOD, 2016, 127 (12) : 1551 - 1558
  • [9] INTENSIVE POSTREMISSION CHEMOTHERAPY IN ADULTS WITH ACUTE MYELOID-LEUKEMIA
    MAYER, RJ
    DAVIS, RB
    SCHIFFER, CA
    BERG, DT
    POWELL, BL
    SCHULMAN, P
    OMURA, GA
    MOORE, JO
    MCINTYRE, OR
    FREI, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (14) : 896 - 903
  • [10] The value of allogeneic and autologous hematopoietic stem cell transplantation in prognostically favorable acute myeloid leukemia with double mutant CEBPA
    Schlenk, Richard F.
    Taskesen, Erdogan
    van Norden, Yvette
    Krauter, Juergen
    Ganser, Arnold
    Bullinger, Lars
    Gaidzik, Verena I.
    Paschka, Peter
    Corbacioglu, Andrea
    Goehring, Gudrun
    Kuendgen, Andrea
    Held, Gerhard
    Goetze, Katharina
    Vellenga, Edo
    Kuball, Juergen
    Schanz, Urs
    Passweg, Jakob
    Pabst, Thomas
    Maertens, Johan
    Ossenkoppele, Gert J.
    Delwel, Ruud
    Doehner, Hartmut
    Cornelissen, Jan J.
    Doehner, Konstanze
    Lowenberg, Bob
    [J]. BLOOD, 2013, 122 (09) : 1576 - 1582
12